{"id":"https://openalex.org/W7219601118","doi":"https://doi.org/10.3389/fonc.2026.1971526","title":"AGE-related efficacy and safety of darolutamide triplet therapy in metastatic hormone-sensitive prostate cancer: are we ready for routine clinical practice?","display_name":"AGE-related efficacy and safety of darolutamide triplet therapy in metastatic hormone-sensitive prostate cancer: are we ready for routine clinical practice?","publication_year":2026,"publication_date":"2026-10-05","ids":{"openalex":"https://openalex.org/W7219601118","doi":"https://doi.org/10.3389/fonc.2026.1971526","pmid":"https://pubmed.ncbi.nlm.nih.gov/42898144","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13677376"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1971526","doi":"https://doi.org/10.3389/fonc.2026.1971526","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1971526","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1971526/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1971526/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110268875","display_name":"Fernando Munoz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Fernando Munoz","raw_affiliation_strings":["Department Radiation Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department Radiation Oncology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078787825","display_name":"Francesco Fiorica","orcid":"https://orcid.org/0000-0002-9404-3655","observed_orcids":["https://orcid.org/0000-0002-9404-3655"]},"institutions":[{"id":"https://openalex.org/I4405263059","display_name":"Azienda ULSS 9 Scaligera","ror":"https://ror.org/01yfn9570","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4405263059"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Fiorica","raw_affiliation_strings":["Department of Medical Oncology, Aulss 9 Scaligera"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Aulss 9 Scaligera","institution_ids":["https://openalex.org/I4405263059"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110268875"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.67631053,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1971526","last_page":"1971526"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/darolutamide","display_name":"darolutamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.5540000200271606},{"id":"https://openalex.org/keywords/metastatic-hormone-sensitive-prostate-cancer","display_name":"metastatic hormone-sensitive prostate cancer","score":0.8700000047683716},{"id":"https://openalex.org/keywords/triplet-therapy","display_name":"triplet therapy","score":0.6679999828338623},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6859999895095825},{"id":"https://openalex.org/keywords/clinical-practice-implementation","display_name":"clinical practice implementation","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8759999871253967},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6521999835968018},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6082000136375427},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5590000152587891},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.5321999788284302},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.37630000710487366},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3142000138759613},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.31360000371932983},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.26159998774528503},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.259799987077713},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.25679999589920044}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.1971526","doi":"https://doi.org/10.3389/fonc.2026.1971526","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1971526","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1971526/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:42898144","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42898144","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13677376","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677376/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:1e3b89fff21d43b4b80c0a838295896b","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/1e3b89fff21d43b4b80c0a838295896b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1971526","doi":"https://doi.org/10.3389/fonc.2026.1971526","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1971526","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1971526/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7219601118.pdf","grobid_xml":"https://content.openalex.org/works/W7219601118.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W2098931866","https://openalex.org/W2149974876","https://openalex.org/W2167600867","https://openalex.org/W2576656535","https://openalex.org/W4415899403"],"related_works":["https://openalex.org/W4415899403","https://openalex.org/W4407701760","https://openalex.org/W4410883391","https://openalex.org/W4410811661","https://openalex.org/W4415939886","https://openalex.org/W4409833230","https://openalex.org/W7162661198","https://openalex.org/W7127419218","https://openalex.org/W7116833607","https://openalex.org/W4319955410"],"abstract_inverted_index":{"The":[0,18,169],"treatment":[1,12,63,126,189,280,424,458,593,640,681,702,733],"of":[2,39,80,148,177,188,213,221,237,305,342,352,384,401,449,494,504,540,549,564,581,651,673,693,700,743,770],"metastatic":[3,164],"hormone-sensitive":[4,165],"prostate":[5,166],"cancer":[6,167],"(mHSPC)":[7],"has":[8,534],"rapidly":[9,198],"evolved,":[10],"with":[11,131,134,152,231,297,373,552,576,616,717,730],"intensification":[13],"becoming":[14],"an":[15,348,584],"established":[16,546],"strategy.":[17],"ARASENS":[19,215,336],"trial":[20,216,544,772],"demonstrated":[21],"a":[22,120,194,232,338,417,427,670],"survival":[23,229],"benefit":[24,548,571,749],"from":[25,445,572,750],"adding":[26],"darolutamide":[27,81,149,222,550],"to":[28,102,125,160,223,278,283,358,387,638,643,676,748,765,775],"androgen":[29,153,585],"deprivation":[30,154],"therapy":[31,83,155,574,716],"(ADT)":[32,156],"and":[33,53,70,78,90,116,141,146,157,245,264,309,315,354,423,453,554,611,647,653,704,739,774],"docetaxel.":[34],"However,":[35],"the":[36,76,117,137,144,178,186,214,219,260,269,285,303,329,382,388,399,405,440,446,479,529,538,543,547,560,630,660,664,767],"optimal":[37],"management":[38],"older":[40,103,129,192,343,525,567,631,724],"patients":[41,104,130,365,568,597,738,761],"remains":[42,205,392],"challenging,":[43],"as":[44,322,404,659],"this":[45,109],"population":[46,195,330,391,632],"is":[47,197,398,416],"often":[48,511],"underrepresented":[49,206],"in":[50,105,128,150,163,182,200,207,335,368,489,524,595,614,721,781],"clinical":[51,91,202,209,246,369,624,771,783],"trials":[52,687],"chronological":[54,402,413,465,645],"age":[55,85,162,290,403,414,477,646],"does":[56,557],"not":[57,272,482,558],"necessarily":[58],"reflect":[59],"biological":[60,421,648],"fitness":[61,422],"or":[62,275,377,501,663],"tolerance.The":[64],"recent":[65],"age-based":[66,211],"analysis":[67,212,261],"by":[68,139,514],"Carles":[69,140],"colleagues":[71,142],"provides":[72,227],"important":[73,562],"information":[74],"on":[75,461,629],"efficacy":[77,145,641,709],"safety":[79,147,234],"triplet":[82,573,715],"across":[84,289],"groups.":[86],"Nevertheless,":[87,239],"several":[88,243],"methodological":[89,244],"issues":[92],"should":[93,171,292,318,598,626,668,688],"be":[94,172,293,313,320,763],"considered":[95],"before":[96,251],"these":[97,114,252,316,385],"findings":[98,253,311,386],"are":[99,254,486,510,726],"broadly":[100,255],"applied":[101],"routine":[106,258,671],"practice.":[107],"In":[108,590],"Opinion":[110],"article,":[111],"we":[112,240],"discuss":[113],"limitations":[115],"need":[118],"for":[119,174,191,420,532,680,736],"more":[121,777],"individualized,":[122,601],"geriatric-informed":[123],"approach":[124],"selection":[127,679],"mHSPC.We":[132],"read":[133],"great":[135],"interest":[136],"article":[138],"evaluating":[143,732],"combination":[151],"docetaxel":[158,226],"according":[159,282,642],"patient":[161,609,678],"(mHSPC).":[168],"authors":[170],"congratulated":[173],"addressing":[175],"one":[176],"most":[179,746],"relevant":[180,508],"challenges":[181],"contemporary":[183,577],"uro-oncology,":[184],"namely":[185],"optimization":[187],"strategies":[190,720],"patients,":[193,491],"that":[196,218,242,412,485],"increasing":[199],"daily":[201],"practice":[203,370,784],"but":[204],"prospective":[208,634,755],"trials.The":[210],"suggests":[217],"addition":[220],"ADT":[224,553,582],"plus":[225,583],"consistent":[228],"benefits":[230],"manageable":[233],"profile":[235],"irrespective":[236],"age.":[238,466],"believe":[241],"aspects":[247],"deserve":[248],"further":[249],"consideration":[250],"translated":[256],"into":[257,439],"practice.First,":[259],"was":[262,271],"exploratory":[263],"conducted":[265],"post":[266,299],"hoc.":[267],"Because":[268],"study":[270,441,480,674],"prospectively":[273],"designed":[274],"statistically":[276],"powered":[277,637],"evaluate":[279,639],"effects":[281],"age,":[284],"apparent":[286],"consistency":[287],"observed":[288],"subgroups":[291],"interpreted":[294],"cautiously.":[295],"As":[296],"all":[298],"hoc":[300],"subgroup":[301],"analyses,":[302],"possibility":[304],"insufficient":[306],"statistical":[307],"power":[308],"chance":[310],"cannot":[312],"excluded,":[314],"results":[317,773],"therefore":[319,599],"regarded":[321],"hypothesis-generating":[323],"rather":[324,463],"than":[325,464],"conclusive.":[326],"[1,2]":[327],"Second,":[328],"aged":[331],"\u226575":[332],"years":[333],"enrolled":[334],"represents":[337],"highly":[339],"selected":[340],"subset":[341],"adults.":[344,526],"Eligibility":[345],"criteria":[346],"required":[347],"ECOG":[349],"performance":[350],"status":[351],"0-1":[353],"adequate":[355],"organ":[356],"function":[357],"receive":[359],"docetaxel,":[360,555],"effectively":[361],"excluding":[362],"many":[363],"elderly":[364,490,596,760],"commonly":[366],"encountered":[367],"who":[371],"present":[372],"frailty,":[374,608],"multimorbidity,":[375],"polypharmacy,":[376],"reduced":[378],"physiological":[379],"reserve.":[380],"Consequently,":[381],"generalizability":[383],"real-world":[389,756],"geriatric":[390,429],"uncertain.":[393],"[3,4]":[394],"An":[395],"additional":[396],"limitation":[397],"use":[400],"principal":[406],"stratification":[407],"variable.":[408],"Increasing":[409],"evidence":[410],"indicates":[411],"alone":[415],"poor":[418],"surrogate":[419],"tolerance.":[425],"Neither":[426],"comprehensive":[428],"assessment":[430],"(CGA)":[431],"nor":[432],"validated":[433,654],"frailty":[434,655],"screening":[435,656],"instruments":[436],"were":[437,473],"incorporated":[438],"protocol,":[442],"despite":[443],"recommendations":[444],"International":[447],"Society":[448],"Geriatric":[450],"Oncology":[451],"(SIOG)":[452],"other":[454],"expert":[455],"societies":[456],"advocating":[457],"decisions":[459,594],"based":[460],"functional":[462,495,694],"[4,5]":[467],"Furthermore,":[468],"although":[469],"treatment-emergent":[470],"adverse":[471],"events":[472],"generally":[474],"comparable":[475],"between":[476],"groups,":[478],"did":[481],"investigate":[483],"outcomes":[484],"particularly":[487],"meaningful":[488],"including":[492],"preservation":[493],"independence,":[496],"cognitive":[497,696],"function,":[498],"mobility,":[499],"falls,":[500],"patientreported":[502,705],"quality":[503,699],"life.":[505],"These":[506],"clinically":[507],"domains":[509],"insufficiently":[512],"reflected":[513],"conventional":[515,707],"CTCAE":[516],"toxicity":[517],"reporting":[518],"yet":[519],"frequently":[520],"influence":[521],"therapeutic":[522,530,612,779],"decision-making":[523,780],"[5]":[527],"Finally,":[528,754],"paradigm":[531],"mHSPC":[533],"evolved":[535],"considerably":[536],"since":[537],"conception":[539],"ARASENS.":[541],"Although":[542],"firmly":[545],"combined":[551],"it":[556],"answer":[559],"increasingly":[561],"question":[563],"whether":[565],"fit":[566,723],"derive":[569],"incremental":[570],"compared":[575],"doublet":[578,719],"regimens":[579],"consisting":[580],"receptor":[586],"pathway":[587],"inhibitor":[588],"alone.":[589],"current":[591,617],"practice,":[592],"remain":[600],"integrating":[602],"disease":[603],"burden,":[604,703],"life":[605],"expectancy,":[606],"comorbidity,":[607],"preferences,":[610],"goals,":[613],"accordance":[615],"SIOG":[618],"recommendations.":[619],"[4]":[620],"Looking":[621],"ahead,":[622],"future":[623,686],"research":[625],"specifically":[627],"focus":[628],"through":[633],"studies":[635,712],"adequately":[636],"both":[644],"fitness.":[649],"Incorporation":[650],"CGA":[652],"tools,":[657],"such":[658],"G8":[661],"questionnaire":[662],"Clinical":[665],"Frailty":[666],"Scale,":[667],"become":[669],"component":[672],"design":[675],"improve":[677],"intensification.":[682],"[3,5]":[683],"Equally":[684],"important,":[685],"include":[689],"geriatric-specific":[690],"endpoints-including":[691],"maintenance":[692],"autonomy,":[695],"outcomes,":[697],"health-related":[698],"life,":[701],"outcomes-alongside":[706],"oncological":[708],"measures.":[710],"Randomized":[711],"directly":[713],"comparing":[714],"modern":[718],"biologically":[722],"adults":[725],"also":[727],"needed,":[728],"together":[729],"investigations":[731],"de-escalation":[734],"approaches":[735],"frail":[737],"predictive":[740],"biomarkers":[741],"capable":[742],"identifying":[744],"individuals":[745],"likely":[747],"intensified":[751],"systemic":[752],"therapy.":[753],"registries":[757],"enrolling":[758],"unselected":[759],"will":[762],"essential":[764],"confirm":[766],"external":[768],"validity":[769],"support":[776],"individualized":[778],"everyday":[782]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-05T00:00:00"}